|
|
||||||||
inhibits estrogen receptor activity by recruiting a protein phosphatase
Department of Obstetrics and Gynecology University School of Medicine, 975 West Walnut Street (IB360), Indianapolis, Indiana 46202, USA1 Department of Medical Sciences Program, Indiana University School of Medicine, Bloomington, Indianapolis, Indiana 47405, USA2 Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
(Correspondence should be addressed to R M Bigsby; Email: rbigsby{at}iupui.edu)
A splicing variant of rat striatin-3 (rSTRN3
) was found to associate with estrogen receptor-
(ER
) in a ligand-dependent manner. In two-hybrid and pull-down analyses, estradiol induced an interaction between rSTRN3
and ER
. STRN3
protein was found in nuclear extracts from rat uterus and human cell lines. Overexpression of rSTRN3
induced a decrease in ER
transcriptional activity but had no effect on ERβ activity. Immunoprecipitation analyses showed that rSTRN3
interacts with both the ER
and the catalytic subunit of protein phosphatase 2A (PP2A(C)). The transrepressor action of rSTRN3
was overcome by okadaic acid, an inhibitor of PP2A(C), and by cotransfection of PP2A(C) siRNA. rSTRN3
caused dephosphorylation of ER
at serine 118 and this was abrogated by okadaic acid. ER
lacking phosphorylation sites at either serine 118 or 167 was insensitive to the corepressor action of rSTRN3
. These observations suggest that an rSTRN3
-PP2A(C) complex is recruited to agonist-activated ER
, thereby leading to its dephosphorylation and inhibiting transcription.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |